trial summary · NCT07755956
Phase Ia Trial of HHK001 Compared With Enantone in Patients With Endometriosis
A Phase Ia Clinical Trial to Compare Pharmacokinetics, Pharmacodynamics, Safety and Preliminary Efficacy of HHK001 Versus Enantone in Patients With Endometriosis
Trial record from the TrialBase DB dataset, status RECRUITING, condition Endometriosis, sponsored by Zhuhai Huahaikang Pharmaceutical Technology Co., Ltd.. Facts below are exported values from the current release, not inferred or edited prose.
Summary
The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.
The goal of this clinical trial is to find out how the study drug HHK001 compares to Enantone (an approved treatment for endometriosis) when given as a single 3.75 mg injection to participants with endometriosis. Both products contain the same active ingredient: leuprorelin acetate. We will check how the body absorbs and responds to each medicine, monitor possible side effects and treatment benefits. Researchers will compare HHK001 to Enantone to test the advantages of its updated formulation.
Source record: https://clinicaltrials.gov/study/NCT07755956
Facts
| registry id | NCT07755956 |
|---|---|
| primary registry | clinicaltrials-gov |
| recruitment status | RECRUITING |
| phase | PHASE1 |
| study type | INTERVENTIONAL |
| lead condition | Endometriosis |
| sponsor | Zhuhai Huahaikang Pharmaceutical Technology Co., Ltd. |
| sponsor class | INDUSTRY |
| enrollment | 20 |
| start date | 2026-10-31 |
| primary completion | 2027-03-31 |
| completion | 2027-03-31 |
| results posted | not reported |
Conditions
- Endometriosis
Interventions
- Leuprorelin Acetate
- Leuprorelin Acetate 3.75mg Injection
Countries
- China
Intervention types: DRUG
Work with this record
- Field definitions
Types, scope, and provenance rules for every exported field.
- REST API
Query the same gate-backed records programmatically.
- Evaluation sample
Download a bounded slice before buying.
- $29 API Pass
Seven days of REST and MCP access; credited toward the licence.